The risk assessment of sleep duration on geriatric sarcopenia and its regulatory role in the effect of BMI index on geriatric sarcopenia based on the CHARLS database
PLOS One · 20.03.2026 · 21 (3) · e0345257
DOI: 10.1371/journal.pone.0345257 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.03.2026. Verfasst von Yan Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Sarcopenia, Sleep Duration, Body Mass Index, Sleep. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Traditional Chinese Medicine Specialty, National Advantageous TCM Specialties.
Abstract (Originalsprache)
Background
The effect of sleep duration on geriatric sarcopenia remains unclear, and evidence of the combined impact of it and BMI on geriatric sarcopenia is scarce.
Aims
To conduct the risk assessment of sleep duration on geriatric sarcopenia and explore its moderating role in the effect of BMI on geriatric sarcopenia based on the CHARLS database.
Methods
Data were extracted from the China Health and Retirement Longitudinal Study (CHARLS) 2011, 2013, and 2015 waves respectively. Logistic regression and Cox regression analyses were conducted to assess the risk of sleep duration for geriatric sarcopenia, and the regulatory effect of sleep duration on the association between BMI and sarcopenia. Subgroup analysis was conducted to enhance the stability of the results.
Results
The four abnormal types of sleep duration were significantly associated with sarcopenia. A significant association between obesity and decreased risk of sarcopenia was observed in sufficient sleep and sleep deprivation groups after the full adjustment of covariates (Adjusted HR = 0.25, 95%CI: 0.10–0.64, P < 0.001; Adjusted HR = 0.13, 95%CI: 0.03–0.53, P = 0.004; Adjusted HR = 0.26, 95%CI: 0.10–0.66, P = 0.005), and relationships of underweight and overweight with sarcopenia were observed in sufficient sleep, sleep deprivation, and mild oversleeping groups. In the group of oversleeping, the associations were not significant.
Conclusion
Abnormal sleep durations including sleep deprivation and oversleeping are linked to a heightened risk of sarcopenia among older adults. Underweight is associated with the increased sarcopenia risk, and overweight is correlated with the decreased risk of sarcopenia, especially in females with abnormal sleep duration except for severe oversleeping, and obesity is associated with the decreased risk of sarcopenia, especially in adults aged over 65 with sleep deprivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
- Department of endocrinology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Yan Chen
Förderung
- National Traditional Chinese Medicine Specialty
- National Advantageous TCM Specialties
Zitieren
APA
Chen, Y., Shi, X. K., Liu, N. N., & Feng, Z. (2026). The risk assessment of sleep duration on geriatric sarcopenia and its regulatory role in the effect of BMI index on geriatric sarcopenia based on the CHARLS database. PLOS One, 21(3), e0345257. https://doi.org/10.1371/journal.pone.0345257
Vancouver
Chen Y, Shi XK, Liu NN, Feng Z. The risk assessment of sleep duration on geriatric sarcopenia and its regulatory role in the effect of BMI index on geriatric sarcopenia based on the CHARLS database. PLOS One. 2026;21(3):e0345257. doi:10.1371/journal.pone.0345257
BibTeX
@article{Chen2026,
author = {Chen, Yan and Shi, Xue-Ke and Liu, Nan-Nan and Feng, Zhihai},
title = {The risk assessment of sleep duration on geriatric sarcopenia and its regulatory role in the effect of BMI index on geriatric sarcopenia based on the CHARLS database},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0345257},
doi = {10.1371/journal.pone.0345257}
}
EUVIMED